177 related articles for article (PubMed ID: 31940417)
1. In vivo expression of peptidylarginine deiminase in Drosophila melanogaster.
Mahneva O; Risley MG; John C; Milton SL; Dawson-Scully K; Ja WW
PLoS One; 2020; 15(1):e0227822. PubMed ID: 31940417
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
[TBL] [Abstract][Full Text] [Related]
4. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
Curran AM; Naik P; Giles JT; Darrah E
Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
[TBL] [Abstract][Full Text] [Related]
5. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
7. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
Wang Y; Chen R; Gan Y; Ying S
Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine Deiminase 2 Knockout Improves Survival in hemorrhagic shock.
Zhou J; Biesterveld BE; Li Y; Wu Z; Tian Y; Williams AM; Tian S; Gao W; Bhatti UF; Duan X; Wang T; Zhang J; Jiang B; Wang Z; Alam HB
Shock; 2020 Oct; 54(4):458-463. PubMed ID: 31764615
[TBL] [Abstract][Full Text] [Related]
9. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage.
Romero V; Darrah E; Andrade F
Arthritis Rheumatol; 2020 Jun; 72(6):912-918. PubMed ID: 31876120
[TBL] [Abstract][Full Text] [Related]
10. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
Li B; Li P; Bi L
Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
[TBL] [Abstract][Full Text] [Related]
11. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine Deiminases 2 Mediates Caspase-1-Associated Lethality in Pseudomonas aeruginosa Pneumonia-Induced Sepsis.
Wu Z; Tian Y; Alam HB; Li P; Duan X; Williams AM; Liu B; Ma J; Li Y
J Infect Dis; 2021 Mar; 223(6):1093-1102. PubMed ID: 32729925
[TBL] [Abstract][Full Text] [Related]
13. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
Darrah E; Rosen A; Giles JT; Andrade F
Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
[TBL] [Abstract][Full Text] [Related]
15. Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis.
Tian Y; Qu S; Alam HB; Williams AM; Wu Z; Deng Q; Pan B; Zhou J; Liu B; Duan X; Ma J; Mondal S; Thompson PR; Stringer KA; Standiford TJ; Li Y
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055424
[TBL] [Abstract][Full Text] [Related]
16. Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and Perspectives.
Wu Z; Li P; Tian Y; Ouyang W; Ho JW; Alam HB; Li Y
Front Immunol; 2021; 12():761946. PubMed ID: 34804050
[TBL] [Abstract][Full Text] [Related]
17. Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies.
Bashar SJ; Holmes CL; Shelef MA
Front Immunol; 2024; 15():1167362. PubMed ID: 38476240
[TBL] [Abstract][Full Text] [Related]
18. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
Damiana T; Damgaard D; Sidelmann JJ; Nielsen CH; de Maat MPM; Münster AB; Palarasah Y
Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
[TBL] [Abstract][Full Text] [Related]
19. The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications.
Tsai CY; Hsieh SC; Liu CW; Lu CH; Liao HT; Chen MH; Li KJ; Wu CH; Shen CY; Kuo YM; Yu CL
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073629
[TBL] [Abstract][Full Text] [Related]
20. Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning.
Badillo-Soto MA; Rodríguez-Rodríguez M; Pérez-Pérez ME; Daza-Benitez L; Bollain-Y-Goytia JJ; Carrillo-Jiménez MA; Avalos-Díaz E; Herrera-Esparza R
Eur J Rheumatol; 2016 Jun; 3(2):44-49. PubMed ID: 27708970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]